Management of Pain Associated With Failed Back Surgery Syndrome

A

Al-Kindy College of Medicine

Status and phase

Completed
Phase 4

Conditions

Failed Back Surgery Syndrome

Treatments

Drug: Gabapentin 300mg
Drug: Pregabalin 75mg

Study type

Interventional

Funder types

Other

Identifiers

NCT05324761
13 Al-KindyCM

Details and patient eligibility

About

Neuropathic pain is a common complication following different types of spine surgery making negative impact on health, along with life style changes and management, many neurologist prescribed either Pregabalin or Gabapentin to manage this condition with overall good results. our study aims to evaluate the efficacy of Pregabalin and Gabapentin in the management of this condition and to compare between them

Enrollment

60 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients with Previous spine surgery and subsequent chronic back pain

Exclusion criteria

  • Patients with connective tissue diseases
  • Patients with psychiatric illnesses

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

60 participants in 2 patient groups

Pregabalin
Active Comparator group
Description:
A dose of 75 mg of Pregabalin twice daily for one month will be prescribed to each patient enrolled this study arm
Treatment:
Drug: Pregabalin 75mg
Gabapentin
Active Comparator group
Description:
A dose of 300 mg of Gabapentin twice daily for one month will be prescribed to each patient enrolled this study arm
Treatment:
Drug: Gabapentin 300mg

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems